Delivery Order SPE2DE21D7020-SPE2D626F514M
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $1,457.55 under a Defense Health Agency Medical Supply Chain contract, with an ultimate completion date of December 16, 2025. This fixed-price delivery order with economic price adjustment was issued on December 9, 2025, for the supply of NC EMERGE MR 15MM medical devices. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents one of multiple awards issued by the...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $4,154.85 by the Defense Health Agency's Medical Supply Chain on July 25, 2025, for the NC EMERGE MR 30MM product. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 1, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award represents a non-set-aside procurement,...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $3,053.05 by the Defense Health Agency's Medical Supply Chain division under contract number 4570108350 for NC EMERGE MR 8MM equipment or supplies. The award, issued on November 26, 2025, is not designated as a small business set-aside, allowing unrestricted competition. The delivery order carries a completion date of December 4, 2025, and will be performed at Boston...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on December 5, 2025, with an ultimate completion date of December 12, 2025, is designated as a fixed-price delivery order with economic price adjustment provisions. This award is issued without small business set-aside restrictions, allowing Boston Scientific to compete on an unrestricted...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,832.60 by the Defense Health Agency's Medical Supply Chain division for a selective multi-conductor single straight 155cm medical device. The contract, awarded on November 5, 2025, carries a fixed price with economic price adjustment pricing structure and is scheduled for completion by November 13, 2025. This delivery order was issued without small business set-aside provisions,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,341.85 by the Defense Health Agency's Medical Supply Chain on July 21, 2025. This fixed-price contract with economic price adjustment provisions is designated as contract number 4568850340 for NC EMERGE MR 20MM equipment, with an ultimate completion date of July 28, 2025. The award represents no set-aside designation, allowing Boston Scientific...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,327.08 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority was awarded on October 15, 2025, with an ultimate completion date of October 22, 2025. The delivery order is issued against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency, a single-award indefinite delivery...
- Boston Scientific Corp has been awarded a delivery order valued at $1,448.32 under the Defense Health Agency's Medical Supply Chain Blanket Purchase Agreement for NC EMERGE MR 30MM products, with an ultimate completion date of December 18, 2025. The award was issued on December 11, 2025, with a fixed price pricing structure that includes economic price adjustment provisions. The contract is being performed in Marlborough, Massachusetts, where Boston Scientific maintains its global headquarters...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F514MDelivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $4,979.10 by the Defense Health Agency's Medical Supply Chain division. The contract, designated as EMERGE MR 15MM, is scheduled for completion by December 4, 2025, and was awarded on November 26, 2025. The delivery order will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This award was made without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The contract includes economic price adjustment provisions, providing flexibility to account for cost fluctuations during performance. This delivery order is issued under Boston Scientific's broader Blanket Purchase Agreement with the Defense Health Agency valued at $750,000, which was awarded on March 31, 2025, and designated as the sole-source vehicle for radiation treatment devices through March 30, 2030. The BPA structure enables the Defense Health Agency to streamline procurement of specialized radiation oncology equipment and related radiopharmaceuticals across military healthcare facilities and Veterans Affairs medical centers. Boston Scientific's extensive federal contracting history demonstrates its established capability to deliver complex medical devices, including cardiovascular, interventional, diagnostic, and neuromodulation solutions to federal healthcare agencies, positioning the company as a critical supplier within the defense and veterans healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/25/25 |